Gemina Laboratories Ltd. (GLAB) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Headlines Articles Press releases Gemina Laboratories Ltd.

Home
Companies
Gemina Laboratories Ltd.

BRIEF

published on 11/13/2024 at 17:05, 7 days 20 hours ago

Gemina Laboratories Announces Private Placement to Raise $7 Million

Private Placement Capital Raising Gemina Laboratories Investment Risks Platform Development
PRESS RELEASE

published on 11/13/2024 at 17:00, 7 days 20 hours ago

Gemina Laboratories Announces Private Placement
Gemina Laboratories Ltd. announces a non-brokered private placement offering to raise up to $7,000,000. Proceeds will support platform development, production expansion, and business development

Private Placement Offering Business Development Production Expansion Gemina Laboratories Ltd. Platform Development
BRIEF

published on 07/10/2024 at 15:05, 4 months 10 days ago

Gemina Laboratories Strategic Update

Revenue Gemina Laboratories Diagnostics Licensing
PRESS RELEASE

published on 07/10/2024 at 15:00, 4 months 10 days ago

Gemina Laboratories Strategic Update
Gemina Laboratories Ltd provides strategic update and progress summary in H1 2024, including new partnerships, maiden revenues, expanded solutions & protein production facility

Partnerships Gemina Laboratories Ltd Strategic Update Protein Production Facility Commercial Revenues
BRIEF

published on 06/20/2024 at 19:05, 5 months ago

Gemina Laboratories Commences Trading on the OTCQB Market in the United States

Investor Relations OTCQB U.S. Market Gemina Laboratories Diagnostics Technology
PRESS RELEASE

published on 06/20/2024 at 19:00, 5 months ago

Gemina Laboratories Commences Trading on the OTCQB Market in the United States
Gemina Laboratories expands investor reach to U.S. by posting shares on OTCQB, enhancing visibility and liquidity. CEO Brian Firth comments on the strategic move

OTCQB OTC Markets Gemina Laboratories Investor Reach Brian Firth
BRIEF

published on 04/09/2024 at 16:05, 7 months 11 days ago

Gemina Labs Announces Addition to its IP Portfolio

Gemina Laboratories IP Portfolio UBC Partnership Point-of-Care Biosensors Tuberculosis Diagnostics
PRESS RELEASE

published on 04/09/2024 at 16:00, 7 months 11 days ago

Gemina Labs Announces Addition to its IP Portfolio
Gemina Laboratories Ltd. announces licensing of novel biosensing architecture from the University of British Columbia. The technology enables affordable high-sensitivity molecular diagnostics for infections like Mycobacterium tuberculosis

Molecular Diagnostics Gemina Laboratories Ltd. Biosensing Architecture University Of British Columbia WHO Target Product Profiles
BRIEF

published on 04/02/2024 at 15:05, 7 months 18 days ago

Gemina Laboratories Announces Strategic Licensing Agreement with Global Diagnostics Company

Intellectual Property Diagnostic Technology Gemina Laboratories License Agreement Global Diagnostics Market
PRESS RELEASE

published on 04/02/2024 at 15:00, 7 months 18 days ago

Gemina Laboratories Sign First Strategic License Agreement
Gemina Laboratories Ltd. announces license agreement with global diagnostics company, validating its technology in the in vitro diagnostics market. CEO Brian Firth highlights cost-saving potential and future partnerships

Partnerships Gemina Laboratories Ltd. License Agreement Diagnostics Market Technology Validation

Accesswire

Published on 11/21/2024 at 13:30, 24 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 24 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 54 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 54 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 54 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 39 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 19 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 39 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 47 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 54 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 56 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 34 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 9 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 9 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE